Straumann¿ Emdogain 015, USA. Enamel Matrix Derivative. Article Number 075.099

FDA Device Recall #Z-1694-2018 — Class II — March 23, 2018

Recall Summary

Recall Number Z-1694-2018
Classification Class II — Moderate risk
Date Initiated March 23, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Straumann Manufacturing, Inc.
Location Andover, MA
Product Type Devices
Quantity 3046

Product Description

Straumann¿ Emdogain 015, USA. Enamel Matrix Derivative. Article Number 075.099

Reason for Recall

A change regarding the shelf life of a raw material was implemented without an appropriate submission of data demonstrating the continued efficacy of the product.

Distribution Pattern

Distributed US Nationwide and Puerto Rico.

Lot / Code Information

Lot LT830, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot LZ706, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MG929, Syringe Blister Lot LK692B, Exp 5/31/2018 Lot MT037, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot MZ441, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ289, Syringe Blister Lot MG253A, Exp 9/30/2018 Lot NJ579, Syringe Blister Lot NA438A, Exp 3/31/2019 Lot NP340, Syringe Blister Lot NA438A, Exp 3/31/2019

Other Recalls from Straumann Manufacturing, Inc.

Recall # Classification Product Date
Z-0455-2019 Class II Neodent¿ GM Mini Conical Abutment - Product Usa... Oct 2, 2018
Z-1698-2018 Class II Straumann¿ Emdogain 0.7 ml Multipack. Enamel Ma... Mar 23, 2018
Z-1695-2018 Class II Straumann¿ Emdogain 0.3 ml Multipack USA. Ename... Mar 23, 2018
Z-1696-2018 Class II Straumann¿ Emdogain 0.3 ml Multipack. Enamel Ma... Mar 23, 2018
Z-1697-2018 Class II Straumann¿ Emdogain 0.7 ml Multipack USA. Ename... Mar 23, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.